2025 Partners

Innovate UK, part of UK Research and Innovation, is the UK’s innovation agency. It works to create a better future by inspiring, involving and investing in businesses developing life-changing innovations. Its mission is to help companies to grow through their development and commercialisation of new products, processes and services, supported by an outstanding innovation ecosystem that is agile, inclusive and easy to navigate.

The National Physical Laboratory (NPL) is a National Laboratory spanning Science, Innovation and Technology. NPL is ideally positioned to support delivery of the multi-disciplinary potential of Engineering Biology (EngBio) through the development of traceable measurement science tools and solutions, necessary for the successful characterisation and exploitation of biological systems.  

Advances in EngBio enabled solutions will be driven through collaboration built on a foundation of reliable, repeatable and comparable measurement systems which are easily transferred between manufacturers in the same way that metrology is critical in other advanced manufacturing disciplines from aircraft to semiconductors. Today, NPL is supporting UK companies to accelerate innovation and enable scale-up of EngBio driven technologies through the development of physical reference materials, standardised analytical methodologies, internationally recognised standards and the development of best practice guidance documents.  

NPL is also collaborating across the EngBio ecosystem both in the UK and internationally to understand and support the next generation of engineering biology solutions, including the requirements for the application of AI and machine learning, the development of process control and modelling systems, alongside support for standards and regulatory requirements working with our partners across the International Measurement System laboratories to ensure UK leadership and alignment on standards and standardisation to support growth and trade.

Potter Clarkson is one of Europe’s leading full service intellectual property (IP) law firms.  We have one simple objective, to maximise the value of your innovation by helping you set the right IP strategy from day one. 

With one of the largest biotech and life sciences team in Europe based across our offices in the UK, Sweden, and Denmark, we are confident there is not a biotech company, invention, or project for which we do not have a specialist!  

Our ability to find exactly the right specialist applies as  much to the commercial side of your business as the technical.  As we are one of the few IP firms to have both IP attorneys and IP solicitors, our teams can also instantly advise on potential licensing opportunities and the other commercial agreements you’ll need to build a successful international business. 

Keltie is a leading European Intellectual Property firm with offices in the UK and Ireland. Our clients benefit from an extraordinarily experienced, multi-faceted group of patent, trade mark and design attorneys who work across a huge range of technology areas, including synthetic biology.

We act for entrepreneurial individuals, start-ups, spin-outs, universities and large corporations who wish to identify, establish, manage and protect their intellectual property in the UK, Europe and worldwide.

We are commercial, driven and fundamentally passionate about what we do: helping to protect the intellectual property of our clients.

Whatever your intellectual property law challenge, we’re ready to help.

Beckman Coulter Life Sciences delivers time-saving solutions in the laboratory through sustainable automation and innovation in liquid handling, genomics, flow cytometry, particle analysis, and centrifugation workflows to advance research and human health for a better tomorrow. 

Ribbon Biolabs is a synthetic biology leader driving DNA synthesis beyond the limits of current technologies. With their automated, enzyme-based platform, Ribbon Biolabs can provide synthetic DNA molecules without size or sequence limitations at a high level of accuracy and at unprecedented speed.

At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture and industrial chemicals, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts. 

Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis, sequencing and therapeutics discovery, providing both the quality and quantity of the tools they need to most rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com. 

As a leader in the synthetic biology landscape, Twist Bioscience is dedicated to enabling researchers and innovators to harness the power of synthetic DNA, addressing some of the world’s most pressing challenges in health, environment, and industry.

Lucideon is a global materials and technology consultancy supporting the biotechnology sector by accelerated product development and commercialisation. At Lucideon, we offer materials expertise, formulation development, and analytical services to startups and established organisations alike. We exploit cross-sector experience to accelerate the development of innovative products, from engineered biological materials to bio-based actives and devices. 

Our biotech solutions span cell-based assay development, microbiological validation, physical characterisation, biocompatibility testing, raw material qualification, and formulation support. Whether you’re engineering microbes or developing sustainable and novel materials, Lucideon provides the scientific insight and materials expertise to reduce risk, demonstrate performance, and get to market faster using our GMP-accredited facilities. 

At Lucideon, we combine deep expertise in materials science with tailored support for biotech innovators working at the intersection of biology, materials, and manufacturing.

OLON is an Italian leader in the production of Active Pharmaceutical Ingredients (APIs), specializes in both synthetic and biological processes for the generic market as well as Contract Development and Manufacturing (CDMO). 

Olon enables biopharmaceutical companies to achieve a faster, leaner, and seamless transition from development to commercialization. By eliminating the need for technology transfer to third parties, Olon’s integrated approach guarantees efficiency and reliability throughout both clinical and commercial phases. 

With recognized expertise in microbial process development combined with industry-leading capabilities in large-scale manufacturing, Olon creates a powerful synergy that equips biopharmaceutical innovators with the agility and trusted expertise required to confidently bring their products from the lab to market. 

With capacity spanning from preclinical development to commercial stages, the group focuses on utilizing cutting-edge technologies to advance innovative therapies. Additionally, Olon offers comprehensive services for the development and production of innovative ADC classes, providing a complete solution—from mAbs to linkers, payloads, conjugation, and fill-and-finish processes. 

CPI catalyses the adoption of advanced technologies and manufacturing solutions to benefit people, places, and our planet.

We’re a pioneering social enterprise that accelerates the development, scale-up and commercialisation of innovations in synthetic biology, biomanufacturing, AgriFoodTech, HealthTech, and sustainable materials. Through our expertise and world-class facilities, we help companies turn laboratory breakthroughs into market-ready products and processes.

At CPI, we’re driving progress in climate-smart agriculture and alternative protein production — supporting the transition to a more resilient global food system. Using advanced fermentation, downstream processing, and formulation techniques, we help innovators develop and scale novel foods, nutraceuticals, and feed ingredients in our food-grade, FSSC 22000-certified laboratories.

Our work also extends to next-generation agricultural inputs, including biostimulants, biofertilisers, and probiotics, to enable more sustainable farming. By bridging biology and manufacturing, CPI helps innovators de-risk scale-up, attract investment, and accelerate commercial success.

Part of the High Commission of Canada in the U.K, the Canadian Trade Commissioner Service (TCS) office in London helps Canadian and British companies and organizations of all sizes grow and succeed internationally.

Whether you’re looking for trusted and reliable suppliers of cutting-edge technologies to boost your productivity and competitiveness worldwide, are looking to expand your business in Canada, or are interested in pursuing innovation and R&D partnerships, our team can assist and connect you to Canada through potential collaborators, funding and support programs and key intelligence.

Engineering Biology is a Gold Open Access journal that publishes original research and insight into the application of engineering science and practice to the design of biological devices and systems for a wide range of applications. The journal encompasses all stages of the design cycle from the development of platform technology and techniques, to industrial and scaling processes, and new technical standards. We welcome contributions from those in academic research, industry professionals, policymakers and all individuals with insights to share into the latest developments and challenges.

Editors-in-Chief: Professor Richard Kitney (Imperial College London) and Dr Chueh Loo Poh (National University of Singapore). Published by the Institution of Engineering and Technology (IET) and Wiley.

http://wileyonlinelibrary.com/iet-enb

Sciad Communications is a leading science marketing and communications agency for the life science, biotech, healthcare and engineering sectors. Our talented team of communicators, scientists, marketeers and designers work with organisations that have a vision to shape the future.

Apoha is the company behind Liquid Brain®, the first full-stack platform that captures high-dimensional behavioural fingerprints of molecules. With Apoha, scientists can now access a new data modality – directly measuring molecular behaviour in motion – to accelerate the discovery, design, and optimisation of molecules across industries.

BugBiome uncovers and harnesses naturally occurring microbes that protect crops from pests. By decoding the interactions between plants, microbes, and pests, we discover new biological modes of action and turn them into effective, sustainable crop protection products

We use breakthroughs in genomics, machine learning, and bioengineering to harness the 99% of microbes that have never been isolated before.  With exclusive access to these previously unculturable microbes, we discover new chemistries that have evolved to be effective, specific, and biodegradable.  Our primary goal is to find novel antimicrobials for healthcare and agriculture towards building a safer and greener future.

We reprogram life’s genetic code to launch a new era in biotechnology. Grounded in pioneering research of Professor Jason Chin in Cambridge, UK, we merge synthetic genomics with engineered translation to unlock biology beyond the 20 canonical amino acids. Together, we build and manufacture peptides and proteins enhanced with new-to-nature chemistries, including next-generation therapeutics.